Life Sciences And Medical Technology Payment Trends: 2023 vs 2024
Life Sciences & Medtech Payment Performance: A Minor Uptick of 1 Point in 2024
The Comparison
- 2023: An analysis of 118 companies within the life sciences and medical technology sectors yielded an average payment performance score of 59.8 out of 100.
- 2024: A slightly smaller sample size of 113 companies showed a marginal increase, achieving an average score of 60.8 out of 100.
What This Means
The one-point increase suggests a nearly static payment environment in life sciences and medtech; while technically positive, the change is so small that factors such as sample selection are likely to be influential. Suppliers looking to improve cash flow should use a late payment calculator to see the impacts of late payments.
One-line summary: Payment performance in Life Sciences & Medtech improved from 59.8 (118 companies) in 2023 to 60.8 (113 companies) in 2024.
Read next
Late payment in the UK is quietly improving — but your invoice still depends on who you sell to
We analysed over 100,000 published UK payment-practice reports. Late payment is falling — from 20% of invoices paid outs
UK Company Payment Practices 2025: Biggest Risers, Fallers & New Entrants
How UK companies' payment practices changed in 2025 — the biggest improvers, the firms slipping, and the strongest new e
Agriculture Payment Practices Report 2025
The UK agriculture sector is significantly outperforming the UK average for payment practices, suggesting a degree of fi
Northern Ireland Payment Trends: 2024 vs 2025
The year-on-year decline of 0.1 points, while statistically insignificant, suggests a stagnation in payment performance